Unilever vs. McCormick: Two Consumer Staples Giants, One Better Buy

Unilever reported FY2025 underlying sales growth of 3.5% (volume +1.5%) with Q4 accelerating to 4.2%, a gross margin of 46.9%, and a new €1.5B share buyback starting Q2 2026 after completing an Ice Cream demerger. McCormick posted FY2025 revenue of $6.84B (+1.73%) with Q4 Consumer sales up 3.9%, but gross margin compressed 130 bps to 38.9% in Q4 and the stock is down ~16% YTD, hitting a 52-week low of $57.29. Key 2026 drivers/risks: McCormick needs gross margin recovery (tariffs, commodity costs, higher interest and tax rate ~24% post-Mexico acquisition), while Unilever faces currency headwinds and is targeting the low end of 4–6% growth despite cleaner portfolio and premium/digital focus.

Analysis

Two distinct strategic archetypes are in play: a portfolio-simplifier that concentrates spend and SKUs, and an acquirer that layers incremental sales onto a more complex cost base. Simplification tends to compress working capital and increase procurement leverage within 2–4 quarters, which can mechanically boost gross margins even if top-line growth is modest; it also concentrates demand into fewer packaging and ingredient SKUs, giving selected suppliers pricing power and making manufacturing footprints easier to right-size.

Contrast that with an acquisitive path: adding geographies or verticals commonly introduces near-term interest, tax, and integration noise that masks organic performance for multiple quarters. The margin recovery investors want is therefore timing-sensitive — if cost passthrough lags or tariffs persist, the market will re-price the acquirer long before synergies arrive, particularly if refinancing windows remain tight.

Key catalysts to watch are tariff resolution, commodity-price normalization, and sequential gross-margin beats over two consecutive quarters; each would flip investor confidence quickly. Tail risks include a sustained commodity shock or tariff escalation that would force margin dilution beyond management’s operational levers and could trigger leverage-related covenant stress within 12–18 months.

Because the market is bifurcating on execution risk versus structural clean-up, the highest-conviction opportunities are relative — owning the cleaner, cash-return-focused business into buyback execution while using option structures to hedge the acquirer’s near-term margin execution risk. Time horizons here are asymmetric: days for headline-driven re-rates, 3–9 months to see margin inflection, and 12+ months for full realization of portfolio simplification or acquisition synergies.

Key Decisions for Investors

• Pair trade (relative value): Go long UL and short MKC size-neutral (e.g., 1.0% net long exposure) for a 6–12 month hold. Rationale: capture expected relative margin visibility and buyback-driven support in the simpler business versus execution/tariff risk in the acquirer. Target relative outperformance ~15–25%; stop-loss if pair moves against you by 8% absolute to limit funding volatility.
• UL income-enhanced exposure: Buy UL stock (1–2% portfolio) and finance by selling 9–12 month OTM calls to harvest yield while retaining upside. Risk/reward: reduces net entry cost and collects yield; downside protected only by premium collected — use a 10% absolute stop if macro FX or persistent commodity shocks emerge.
• MKC downside hedge: Buy a 4–6 month put spread on MKC sized to 1% portfolio (max loss = premium). Objective: ~40–70%+ return if sequential margin misses recur or tariff news deteriorates ahead of a full-year update. This caps downside cost and gives asymmetric payoff if market re-prices the acquisition risk.
• Event-triggered add: If MKC posts two consecutive quarterly gross-margin recoveries and guidance stabilizes, convert the put hedge into a modest long (0.5–1% add) within one quarter of the second beat, targeting 20–30% upside as analysts re-rate leverage to margin normalization.